NaviFUS Corporation is a medical device company specializing in non-invasive, precise, and cost-effective focused ultrasound (FUS) solutions for clinically unmet needs. Many brain-related diseases currently lack effective drug treatments, as drug delivery to the brain remains a major hurdle to translational therapy; some diseases are also resistant to drug therapy. NaviFUS aims to drive revolutionary clinical solutions for patients through FUS interventions while also providing value to pharmaceutical companies by potentially enhancing drug efficacy. NaviFUS technology originates from the innovative research of founder and Chief Technical Consultant, Dr. Hao-Li Liu, which has been architected into two main platforms: 1) NaviFUS System FUS device – FUS system that can temporarily open the BBB or help reduce epilepsy symptoms; it has 3 different models in development (preclinical research model, animal FUS therapy model, and clinical research model) and 2) NAVIRFA Needle Tracking System – optical tracking system that visualizes the location, orientation, and projected trajectory of needles used in minimally invasive surgeries; research is currently in development for its usage with radiofrequency ablation needles, but other planned clinical applications include biopsy, pain management, and other procedures.